Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Understanding the superiority and occurrence fees of gastroesophageal reflux sickness (GERD) and non-erosive reflux ailment (NERD) across distinct demographics and geographical regions is important for market evaluation. Factors consisting of dietary habits, weight problems, and lifestyle choices contribute to variations in occurrence rates, shaping market demand for associated treatment options. Advancements in diagnostic strategies, including endoscopy, pH tracking, and esophageal manometry, facilitate accurate diagnosis and evaluation of GERD and NERD Treatment. Improved diagnostic capabilities affect market demand for personalized treatment strategies tailor-made to the severity and underlying causes of reflux ailment. Evaluating the variety and efficacy of remedy options for GERD and NERD Treatment, together with lifestyle changes, medicinal drug therapy, and surgical interventions, is crucial.
Increasing public awareness about GERD and NERD Treatment, their symptoms, and treatment alternatives is crucial for early intervention and advanced patient outcomes. Educational tasks concentrated on patients, caregivers, and healthcare professionals play an essential function in shaping market demand and healthcare guidelines associated with reflux disease management. Economic factors, consisting of healthcare expenditure and compensation policies for reflux disease remedies, affect the affordability and accessibility of GERD and NERD Treatment control. Market dynamics are motivated by factors that include government healthcare spending, private insurance coverage, and out-of-pocket prices for patients seeking reflux disease treatment. The competitive panorama of organizations concerned with GERD and NERD Treatment remedies is characterized by the presence of pharmaceutical corporations, clinical tool manufacturers, and healthcare provider providers.
Understanding the demographic profile of individuals with GERD and NERD Treatment, which includes age, gender, and comorbidities, allows pick out market opportunities and tailor healthcare offerings accordingly. Demographic traits influence market demand and the improvement of centered interventions for particularly affected person populations, impacting resource allocation and treatment techniques. Exploring potential boom possibilities in rising markets, including areas with increasing urbanization and adoption of Western dietary styles, is essential for market enlargement techniques. Factors that include regulatory demanding situations, market right of entry to barriers, and cultural issues impact market penetration and product adoption in those areas. Monitoring technological improvements in reflux sickness management, including wearable gadgets for symptom monitoring, advanced surgical strategies, and targeted drug delivery systems, gives insights into destiny market developments and possibilities.
GERD and NERD Treatment Market Highlights:
Americas GERD & NERD Treatment Market
The GERD & NERD Treatment Market Size was valued at USD 1.97 Billion in 2023. The Global GERD & NERD Treatment industry is projected to grow from USD 2.16 Billion in 2024 to USD 4.19 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.63% during the forecast period (2024 - 2032).
Over the last two hundred years, acid reflux has been a common lifestyle problem and also experienced a few setbacks in the U.S. Though, the ultimate goal of the gastroesophageal reflux treatment has always remained the same, which is to suppress the symptoms of the GERD patient. GERD affects up to 40% of the U.S. population in their lifetime and is a part of an increasingly significant public health burden. When GERD is not properly managed, it can lead to Barrett's esophagus. The lifetime risk of progression from GERD to Barrett's esophagus is 26.5%. Early diagnosis and treatment of Barrett's esophagus are crucial because it is the primary risk factor for esophageal cancer. The incidence of acid reflux disorder, also known as heartburn, is rapidly increasing worldwide. Various studies state that almost every person experiences acid reflux once in a lifetime. GERD is one of the commonly observed recurrent gastrointestinal disorders worldwide. The prevalence of acid reflux and related symptoms has increased across the globe by nearly 50% over the last decade. This disorder not only has major effects on the health and quality of patient lives but also extends to the healthcare system and economy.
The major driving factors for growth of the Americas GERD & NERD treatment market are increasing cases of smoking, rising cases of reflux disorder during pregnancy, changing lifestyle, and irregular dietary habits. Moreover, increasing incidence of acid reflux disorder (heartburn), growing geriatric population are likely to fuel the market growth during the forecast period.
Intended Audience:
- Medical Research Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
Research Methodology:
Source: National Center for Biotechnology Information, U.S. National Library of Medicine, U.S. Food and Drug Administration, National Institute of Standards and Technology, U.S. Department of Commerce, Eurostat, Cambridge University Hospitals, Directorate of Industries, Expert Interviews, Annual reports, White paper, Company Presentation, MRFR Analysis
Segmentation
The Americas GERD & NERD treatment market is segmented on the basis of drug class, dosage form, and by the end user.
On the basis of the drug class, the Americas GERD & NERD treatment market is segmented into antacids (acid neutralizers), proton pump inhibitors, H2 receptor blocker, prokinetic agents, antidepressants, calcium channel blockers, and others. Proton pump inhibitors are further segmented into esomeprazole, omeprazole, pantoprazole, lansoprazole, dexlansoprazole, rabeprazole, and others. H2 receptor blocker is further segmented into ranitidine, famotidine, cimetidine, nizatidine, and others. Prokinetic agents are further segmented into domperidone, metoclopramide, itopride, prucalopride, cisapride, benzamide, mosapride, erythromycin, and others.
Based on the dosage form, Americas GERD & NERD treatment market is segmented into solid and liquid.
On the basis of the end user, Americas GERD & NERD treatment market is segmented into hospitals & clinics, research centers, and others.
Regional Analysis
The Americas GERD & NERD treatment market is growing at a steady pace. North America contributed the largest share to the GERD & NERD treatment market owing to continuously increasing demand for the medical devices, increasing number of healthcare organization, and the presence of huge patient population. Increasing cases of smoking are projected to fuel in the Americas market. The South American region accounts the least share of the market.
Key Findings:
- Antacids segment dominates the market with nearly 26.11% share of the Americas GERD & NERD treatment market
- Americas GERD & NERD treatment market was estimated to be USD 2,350.37 million in 2016
- Proton pump inhibitors segment is expected to be the second largest market, which is expected to reach USD 773.62 million by 2023
Key Players in the Americas GERD & NERD Treatment Market
Some of the major players in Americas GERD & NERD treatment are: AstraZeneca Plc (U.K), Boston Scientific Corporation (U.S.), Cempra Inc. (U.S.), Eisai Co., Ltd. (Japan), EndoGastric Solutions Inc. (U.S.), EndoStim Inc. (U.S.), GlaxoSmithKline Plc (U.K), Ironwood Pharmaceuticals, Inc. (U.S.), Jeil pharmaceutical Co. Ltd. (South Korea), Johnson & Johnson (U.S.), Mederi Therapeutics Inc. (U.S.), Medigus Ltd. (Israel), Medtronic Inc. (U.S.), Merck & CO., Inc. (U.S.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Takeda Pharmaceutical Company Limited (Japan), Teva Pharmaceuticals Industries Limited (Israel), Torax Medical (U.S.), Valeant Pharmaceuticals International, Inc. (Canada), Carbon Medical technologies (U.S.), Allegiant health (U.S.), Tya pharmaceuticals (U.S.), and Sanofi (France).
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
